Showing 37,981 - 38,000 results of 67,858 for search '(( 05 0 decrease ) OR ( 50 ((((a decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 0.72s Refine Results
  1. 37981
  2. 37982

    Biomechanical effects of the abductor hip muscles local fatigue by Márcio Goethel (8995541)

    Published 2020
    “…When the volunteer failed to repeat the movements, the maximal voluntary isometric contraction of hip abduction was immediately tested using an isokinetic dynamometer Biodex System 4<sup>®</sup>, in order to verify if there was a decrease of at least 50% in torque peak. Once fatigue observed, the volunteer was conducted to perform the tasks of squatting or drop landing, with no relevant resting period. …”
  3. 37983
  4. 37984

    Presentation_1_The Successional Changes in the Gut Microbiome of Pasture-Raised Chickens Fed Soy-Containing and Soy-Free Diets.pdf by Jeferson M. Lourenco (6702122)

    Published 2019
    “…Results showed that at the phylum level, regardless of diet and birds' stage of life, there was a predominance of the phylum Firmicutes, which ranged from 50 to 90% of all OTUs in all samples. …”
  5. 37985

    Figures of manuscript "Fluvoxamine exerts anti-influenza(H1N1) effects through inhibiting apoptosis pathway" by Zhenqiao Wei (22372648)

    Published 2025
    “…This study evaluated the anti-influenza effects of fluvoxamine using H1N1-infected BALB/c mice and found that compared to the H1N1 infection group, the survival rate of mice in the fluvoxamine intervention group increased by 30% (50% <i>vs</i> 20%), with a decreased trend in body weight loss and improved lung tissue lesions. …”
  6. 37986

    Table 1_Real-world first-line serplulimab therapy for advanced esophageal cancer: effectiveness, safety, and clinical implications.docx by Fei Yan (128878)

    Published 2025
    “…Only two serious adverse events were reported (one hyperkalemia and one decreased white blood cell count).</p>Conclusion<p>This real-world study supports the effectiveness and safety of serplulimab-based regimens as a first-line treatment for patients with locally advanced or metastatic esophageal cancer, regardless of their diverse characteristics.…”
  7. 37987

    Optimization of 4,6-Disubstituted Pyrido[3,2‑<i>d</i>]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell Growth by Yu Han (251741)

    Published 2021
    “…Dual inhibitors of MNKs and PIMs have not been developed. We developed a novel 4,6-disubstituted pyrido­[3,2-<i>d</i>]­pyrimidine compound <b>21o</b> with selective inhibition of MNKs and PIMs. …”
  8. 37988
  9. 37989
  10. 37990
  11. 37991
  12. 37992
  13. 37993
  14. 37994
  15. 37995
  16. 37996
  17. 37997
  18. 37998
  19. 37999
  20. 38000